Shinichi Kageyama

4PUBLICATIONS
20CO-AUTHORS
Solid tumoursMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 04, 2023
Safety and Efficacy of NY-ESO-1 Antigen-Specific T-Cell Receptor Gene-Transduced T Lymphocytes in Patients with Synovial Sarcoma: A Phase I/II Clinical Trial.

Akira Kawai, Mikiya Ishihara, Tomoki Nakamura

|Jun 29, 2022
NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome.

Mikiya Ishihara, Shigehisa Kitano, Shinichi Kageyama

|Apr 16, 2022
Prognostic significance of NY-ESO-1 antigen and PIGR expression in esophageal tumors of CHP-NY-ESO-1-vaccinated patients as adjuvant therapy.

Yasuhiro Nagata, Shinichi Kageyama, Takeshi Ishikawa

|Mar 22, 2021
Safety and antibody immune response of CHP-NY-ESO-1 vaccine combined with poly-ICLC in advanced or recurrent esophageal cancer patients.

Takeshi Ishikawa, Shinichi Kageyama, Yoshihiro Miyahara

Pageof 1

Frequent Collaborators

2 joint publications

Mikiya Ishihara

2 joint publications

Shigehisa Kitano

1 joint publications

Tetsuro Sasada

1 joint publications

Akira Kawai